147 related articles for article (PubMed ID: 38508608)
21. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
[TBL] [Abstract][Full Text] [Related]
22. Histologic Features of Hysterectomy Specimens From Female-Male Transgender Individuals.
Khalifa MA; Toyama A; Klein ME; Santiago V
Int J Gynecol Pathol; 2019 Nov; 38(6):520-527. PubMed ID: 30252728
[TBL] [Abstract][Full Text] [Related]
23. Gynecologic Health Care Providers' Willingness to Provide Routine Care and Papanicolaou Tests for Transmasculine Individuals.
Shires DA; Prieto L; Woodford MR; Jaffee KD; Stroumsa D
J Womens Health (Larchmt); 2019 Nov; 28(11):1487-1492. PubMed ID: 31411513
[No Abstract] [Full Text] [Related]
24. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
[TBL] [Abstract][Full Text] [Related]
25. Retrospective review of changes in testosterone dosing and physiologic parameters in transgender and gender-diverse individuals following hysterectomy with and without oophorectomy.
Grimstad FW; Fraiman E; Garborcauskas G; Ferrando CA
J Sex Med; 2023 Apr; 20(5):690-698. PubMed ID: 36987750
[TBL] [Abstract][Full Text] [Related]
26. Six Tips for Giving Good Health Care to Anyone With a Cervix.
Sallans RK
AMA J Ethics; 2020 Feb; 22(2):E168-175. PubMed ID: 32048589
[TBL] [Abstract][Full Text] [Related]
27. Qualitative Study of Cervical Cancer Screening Among Lesbian and Bisexual Women and Transgender Men.
Johnson MJ; Nemeth LS; Mueller M; Eliason MJ; Stuart GW
Cancer Nurs; 2016; 39(6):455-463. PubMed ID: 26859282
[TBL] [Abstract][Full Text] [Related]
28. Transgender and non-binary peoples experiences of cervical cancer screening: A scoping review.
Rivers G; Hinchliff S; Thompson J
J Clin Nurs; 2024 Jun; 33(6):2112-2122. PubMed ID: 38334194
[TBL] [Abstract][Full Text] [Related]
29. Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians.
Potter J; Peitzmeier SM; Bernstein I; Reisner SL; Alizaga NM; Agénor M; Pardee DJ
J Gen Intern Med; 2015 Dec; 30(12):1857-64. PubMed ID: 26160483
[TBL] [Abstract][Full Text] [Related]
30. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
Jain BB; Adhikary T; Sadhukhan PC; Nandi A
J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
[TBL] [Abstract][Full Text] [Related]
31. Clinical correlation of cervical cancer screening using Pap smear test.
Sharif YH
J Popul Ther Clin Pharmacol; 2022; 29(1):e1-e8. PubMed ID: 35686892
[TBL] [Abstract][Full Text] [Related]
32. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy.
Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL
Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596
[TBL] [Abstract][Full Text] [Related]
33. Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: A systematic narrative review.
Connolly D; Hughes X; Berner A
Prev Med; 2020 Jun; 135():106071. PubMed ID: 32243938
[TBL] [Abstract][Full Text] [Related]
34. Cytology and LGBT+ health: establishing inclusive cancer screening programs.
Compton ML; Taylor SS; Weeks AG; Weiss VL; Hogan MM; Wang H; Ely KA
J Am Soc Cytopathol; 2022; 11(5):241-252. PubMed ID: 35840516
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk.
Brown B; Poteat T; Marg L; Galea JT
LGBT Health; 2017 Oct; 4(5):315-319. PubMed ID: 28876211
[TBL] [Abstract][Full Text] [Related]
36. Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand.
Carroll R; Tan KKH; Ker A; Byrne JL; Veale JF
Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):448-453. PubMed ID: 37005094
[TBL] [Abstract][Full Text] [Related]
37. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
[TBL] [Abstract][Full Text] [Related]
38. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
Berzansky I; Reynolds CA; Charlton BM
Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
[TBL] [Abstract][Full Text] [Related]
39. Barriers to Evidence-Based Transgender Care: Knowledge Gaps in Gender-Affirming Hysterectomy and Oophorectomy.
Reilly ZP; Fruhauf TF; Martin SJ
Obstet Gynecol; 2019 Oct; 134(4):714-717. PubMed ID: 31503150
[TBL] [Abstract][Full Text] [Related]
40. Incidence of breakthrough bleeding in transgender and gender-diverse individuals on long-term testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
Am J Obstet Gynecol; 2024 Apr; 230(4):434.e1-434.e10. PubMed ID: 38181830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
